S.D. Admin. R. 20:48:04:09

Current through Register Vol. 51, page 67, December 16, 2024

Section 20:48:04:09 - Scope and standards of nurse anesthetist practice - Controlled substance prescribing

Prior to prescribing any controlled substances listed in SDCL chapter 34-20B, a nurse anesthetist who meets state and federal controlled substance registration requirements, shall register with the state's prescription drug monitoring program and meet the requirements of SDCL chapter 34-20E.

The standards for documentation of patient care when prescribing controlled substance drugs for the treatment of chronic, non-cancer pain include:

(1) Documentation of results of medical examinations, diagnostic or laboratory tests;

(2) Documentation of a patient's medical and psychosocial history;

(3) Documentation of advanced comprehensive nursing assessment;

(4) Documentation that appropriate state prescription drug monitoring programs were accessed;

(5) Documentation of a patient's treatment agreement, if used;

(6) Documentation of having provided instructions to the patient, or the patient's representative, of the benefits and risks of controlled substances, the proper use and storage of drugs, and the proper disposal of unused drugs;

(7) If prescribing opioid drugs, documentation of instructions including the risk of addiction, overdose, and death, and the use of naloxone products to reverse an overdose;

(8) Documentation of progress of pain management and functional improvement; and

(9) Documentation of collaboration with other health care providers.

Chronic pain means an ongoing, recurrent, or persistent pain that:

(a) lasts beyond the usual course of an acute illness or injury; or

(b) is at least three months in duration.

S.D. Admin. R. 20:48:04:09

47 SDR 073, effective 12/21/2020

General Authority: SDCL 36-9-3.1.

Law Implemented: SDCL 36-9-3.1. 1-26, 34-20B. 34-20E. 36-9-49(5), (7), and (10).